携手借助AI辅助进行病理诊断:EMPAIA倡议
Joining Forces for Pathology Diagnostics with AI Assistance: The EMPAIA Initiative
AI总结:
EMPAIA倡议通过开发开源平台与标准化接口,整合病理AI生态系统的多方利益相关者,成功集成14款AI应用并在14个实验室评估,推动AI辅助病理诊断的标准化与临床应用。
摘要:
在过去十年中,病理学中的人工智能(AI)方法取得了实质性进展。然而,由于在将研究结果转化为临床诊断产品时面临技术和监管障碍,以及缺乏标准化接口等众多挑战,其融入常规临床实践的进程十分缓慢。开放且供应商中立的EMPAIA倡议旨在应对这些挑战。在此,我们概述了EMPAIA的成果与经验教训。EMPAIA整合了病理AI生态系统的各方利益相关者,即病理学家、计算机科学家和工业界。通过密切合作,我们开发了技术互操作性标准、AI测试与产品开发建议以及可解释性方法。我们实施了模块化的开源EMPAIA平台,并成功集成了来自8家不同供应商的14款基于AI的图像分析应用,展示了不同应用如何使用单一标准化接口。我们确定了需求优先级,并在欧洲和亚洲的14个不同病理实验室中评估了AI在真实临床环境中的应用。除了技术开发外,我们还为所有利益相关者创建了一个论坛,以分享有关数字病理学和AI的信息与经验。商业、临床和学术利益相关者现在可以采用EMPAIA的通用开源接口,这为大规模标准化和流程优化提供了独特机会。要有效且广泛地在实验室常规使用中建立AI辅助,仍需进一步努力。为此,一个可持续的基础设施——非营利协会EMPAIA International已经成立,以继续推进标准化,并支持AI辅助数字病理学未来的广泛实施与倡导。
英文摘要:
Over the past decade, artificial intelligence (AI) methods in pathology have advanced substantially. However, integration into routine clinical practice has been slow due to numerous challenges, including technical and regulatory hurdles in translating research results into clinical diagnostic products and the lack of standardized interfaces. The open and vendor-neutral EMPAIA initiative addresses these challenges. Here, we provide an overview of EMPAIA's achievements and lessons learned. EMPAIA integrates various stakeholders of the pathology AI ecosystem, i.e., pathologists, computer scientists, and industry. In close collaboration, we developed technical interoperability standards, recommendations for AI testing and product development, and explainability methods. We implemented the modular and open-source EMPAIA platform and successfully integrated 14 AI-based image analysis apps from 8 different vendors, demonstrating how different apps can use a single standardized interface. We prioritized requirements and evaluated the use of AI in real clinical settings with 14 different pathology laboratories in Europe and Asia. In addition to technical developments, we created a forum for all stakeholders to share information and experiences on digital pathology and AI. Commercial, clinical, and academic stakeholders can now adopt EMPAIA's common open-source interfaces, providing a unique opportunity for large-scale standardization and streamlining of processes. Further efforts are needed to effectively and broadly establish AI assistance in routine laboratory use. To this end, a sustainable infrastructure, the non-profit association EMPAIA International, has been established to continue standardization and support broad implementation and advocacy for an AI-assisted digital pathology future.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。